Regional Monitoring of CF Lung Disease

RecruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

January 5, 2024

Primary Completion Date

January 31, 2028

Study Completion Date

January 31, 2028

Conditions
Cystic Fibrosis
Interventions
DRUG

Hyperpolarized Xe129

Hyperpolarized Xe MRI is FDA Approved for Adults and Children 12 and above We have been performing Xe MRI for research in human subjects for over 20 years, and for over 10 years at CCHMC. Recent FDA approval of hyperpolarized Xe MRI for ventilation stands as a testament to its safety and value as a modern tool for exploring lung disease and function. Earlier studies using Xe MRI have shown its efficacy in exploring CF and other lung diseases in pediatric and adult populations, and it has been found to be much more sensitive to early lung disease than traditional metrics like spirometry and MBW

Trial Locations (1)

45229

RECRUITING

Cincinnati Children's Hospital, Cincinnati

All Listed Sponsors
lead

Children's Hospital Medical Center, Cincinnati

OTHER